SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense investor scrutiny as heavy capital expenditures on AI infrastructure significantly pressure free cash flow despite strong ad revenue growth. The market is actively debating whether these aggressive infrastructure investments will deliver long-term returns or if the company is overspending at the expense of shareholder value.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending following an exceptionally strong half-year earnings report that featured a material beat on revenue and profits, alongside a significant raise to full-year guidance. The community is actively discussing the companys improved margins across all divisions, the successful momentum of its Small Modular Reactor (SMR) nuclear projects, and the expectation for continued stock buybacks.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is experiencing intense volatility driven by shifting sentiment around Federal Reserve interest rate policy, geopolitical tensions in the Middle East, and mixed mega-cap earnings results. The community is actively debating the sustainability of current AI-related valuations, with many traders closely monitoring bond yields and foreign market volatility for clues on potential near-term market direction.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad approval of ANKTIVA for bladder and lung cancer treatments, a significant milestone that adds to the company's growing international regulatory footprint. Investors are actively discussing the potential for global expansion and revenue growth, while many monitor the high short interest and upcoming earnings for signs of a potential squeeze.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing intense volatility as investors weigh strong defense contract wins and new infrastructure expansion against significant share dilution and sector-wide weakness. Community sentiment is deeply divided, with bulls pointing to the company's solid backlog and long-term space-biotech potential, while bears are focused on the persistent downward price trend and the lack of sustained institutional buying to counteract recent supply increases.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as bond market participants react to intensifying geopolitical volatility in the Strait of Hormuz and ongoing inflation concerns, which have driven yields higher and weighed on treasury prices. The community is actively debating whether current long-duration bond levels represent a capitulation bottom or a signal of further structural decline, with traders monitoring how Federal Reserve policy and energy price fluctuations will shape future interest rate trajectories.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense downward pressure as investors grow increasingly skeptical of its high valuation and the company's shift toward speculative AI and robotics projects. The community is sharply divided, with bearish traders aggressively targeting the $300 support level while hopeful bulls continue to debate whether to buy the dip or await further capitulation.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is facing significant downward pressure as investors navigate a broader market rotation and institutional index rebalancing, leading the community to debate whether this is a fundamental breakdown or a temporary liquidity event. While some investors are expressing frustration over the lack of recent contract announcements and the impact of sector-wide volatility, others are actively accumulating shares, viewing the current price as a deep-value opportunity based on long-term demand for NDAA-compliant battery technology in the defense and drone sectors.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as investors react to a stronger-than-expected quarterly earnings report, which highlighted a successful start to the company's turnaround efforts and a raised full-year outlook. The community is actively debating the sustainability of this momentum, contrasting Starbucks' enterprise efficiency initiatives against ongoing concerns over margin risk, high valuation, and intensifying competition from lower-cost coffee chains.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is surging as investors react to a new Schedule 13G filing revealing a 6.2% equity stake from BlackRock, signaling major institutional confidence. The community is actively discussing the companys role in securing a domestic 'mine-to-magnet' supply chain ahead of the 2027 Department of Defense mandate, with many weighing the long-term strategic value of these government and defense-linked partnerships against recent stock volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook

 Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure. 

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike

 Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors. 

Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet

 LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker. 

The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

 ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care. 

REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief

Equity

The New York Times reported that Makary’s departure was driven in large part by his strong opposition to the administration’s decision to authorize fruit-flavored e-cigarettes.


Trump Slaps 100% Tariffs On Imported Patented Drugs, Sparing Companies That Onshore Or Cut Prices

The new levies apply to patented drugs made in countries with which the U.S. have no tariff deals and by companies that haven’t inked drug pricing deals with the administration.


iShares Trust - iShares U.S. Pharmaceuticals ETF

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

IHEiShares U.S. Pharmaceuticals ETF

Fundamentals

Latest IHE News